StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck 2024 Restructuring Program (Supply Network & Commercial Optimization) — Cumulative Charges Incurred Since Inception ($M) ($M)

Form 10-Q / 10-K Restructuring Footnote

QuarterlyAnnual
Latest, Q2 2026
1,900
Period ended Jun 30, 2026
Change on a year earlier
+46.2%
1,300 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
10
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEnded2024 Restructuring Program (Supply Network & Commercial Optimization) — Cumulative Charges Incurred Since Inception ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,900+46.2%Form 10-Q (filed 2026-08-07) ↗
Q1 2026Mar 31, 20261,800+50.0%Form 10-Q (filed 2026-05-04) ↗
Q4 2025Dec 31, 20251,600+45.5%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 20251,400+57.0%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20251,300+112.1%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 20251,200+175.2%Form 10-Q (filed 2025-05-02) ↗
Q4 2024Dec 31, 20241,100–Form 10-K (filed 2025-02-25) ↗
Q3 2024Sep 30, 2024892–Form 10-Q (filed 2024-11-06) ↗
Q2 2024Jun 30, 2024613–Form 10-Q (filed 2024-08-05) ↗
Q1 2024Mar 31, 2024436–Form 10-Q (filed 2024-05-03) ↗

Cite this data

StockData. (2026). Merck 2024 Restructuring Program (Supply Network & Commercial Optimization) — Cumulative Charges Incurred Since Inception ($M) ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/restr_program2024_cum

See every metric in the Merck KPI table. Data updated Oct 26, 2026.